Found: 27
Select item for more details and to access through your institution.
Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism.
- Published in:
- Nephrology Dialysis Transplantation, 2020, v. 35, n. 10, p. 1769, doi. 10.1093/ndt/gfz039
- By:
- Publication type:
- Article
Errata.
- Published in:
- Nephrology Dialysis Transplantation, 2020, v. 35, n. 9, p. 1642, doi. 10.1093/ndt/gfz111
- By:
- Publication type:
- Article
Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The spectrum of response to erenumab in patients with chronic migraine and subgroup analysis of patients achieving ≥50%, ≥75%, and 100% response.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraine.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Cinacalcet HCl reduces hypercalcemia in primary hyperparathyroidism across a wide spectrum of disease severity.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Early onset of efficacy with erenumab for migraine prevention in Japanese patients: Analysis of two randomized, double‐blind, placebo‐controlled studies.
- Published in:
- Brain & Behavior, 2022, v. 12, n. 3, p. 1, doi. 10.1002/brb3.2526
- By:
- Publication type:
- Article
Cinacalcet Treatment of Primary Hyperparathyroidism: Biochemical and Bone Densitometric Outcomes in a Five-Year Study.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2009, v. 94, n. 12, p. 4860, doi. 10.1210/jc.2009-1472
- By:
- Publication type:
- Article
Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidism.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED-HF study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF).
- Published in:
- 2013
- By:
- Publication type:
- journal article
Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF).
- Published in:
- European Journal of Heart Failure, 2013, v. 15, n. 3, p. 334, doi. 10.1093/eurjhf/hfs204
- By:
- Publication type:
- Article
Efficacy of erenumab in chronic migraine patients with and without ictal allodynia.
- Published in:
- Cephalalgia, 2021, v. 41, n. 11/12, p. 1152, doi. 10.1177/03331024211010305
- By:
- Publication type:
- Article
Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extension.
- Published in:
- Cephalalgia, 2021, v. 41, n. 1, p. 6, doi. 10.1177/0333102420973994
- By:
- Publication type:
- Article
Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury.
- Published in:
- FASEB Journal, 2006, v. 20, n. 11, p. 1898, doi. 10.1096/fj.06-5898fje
- By:
- Publication type:
- Article
Long‐term efficacy and safety of erenumab in migraine prevention: Results from a 5‐year, open‐label treatment phase of a randomized clinical trial.
- Published in:
- European Journal of Neurology, 2021, v. 28, n. 5, p. 1716, doi. 10.1111/ene.14715
- By:
- Publication type:
- Article
Long‐term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 6, p. 730, doi. 10.1111/head.14536
- By:
- Publication type:
- Article
Long‐term efficacy and safety of erenumab in patients with chronic migraine in whom prior preventive treatments had failed: A subgroup analysis.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 5, p. 624, doi. 10.1111/head.14313
- By:
- Publication type:
- Article
Erenumab treatment for migraine prevention in Japanese patients: Efficacy and safety results from a Phase 3, randomized, double‐blind, placebo‐controlled study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 6, p. 927, doi. 10.1111/head.14138
- By:
- Publication type:
- Article
Long‐term efficacy and safety during open‐label erenumab treatment in Japanese patients with episodic migraine.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 4, p. 653, doi. 10.1111/head.14096
- By:
- Publication type:
- Article
A Randomized Phase 2 Study of Erenumab for the Prevention of Episodic Migraine in Japanese Adults.
- Published in:
- Headache: The Journal of Head & Face Pain, 2019, v. 59, n. 10, p. 1731, doi. 10.1111/head.13652
- By:
- Publication type:
- Article
Early onset of efficacy with erenumab in patients with episodic and chronic migraine.
- Published in:
- Journal of Headache & Pain, 2018, v. 19, n. 1, p. 1, doi. 10.1186/s10194-018-0923-6
- By:
- Publication type:
- Article
Efficacy and safety of erenumab in Japanese migraine patients with prior preventive treatment failure or concomitant preventive treatment: subgroup analyses of a phase 3, randomized trial.
- Published in:
- Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-021-01313-8
- By:
- Publication type:
- Article
Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trials.
- Published in:
- Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-021-01292-w
- By:
- Publication type:
- Article
Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED-HF study.
- Published in:
- European Journal of Heart Failure. Supplements, 2018, v. 20, n. 2, p. 268, doi. 10.1002/ejhf.988
- By:
- Publication type:
- Article